| P2093 | author name string | Bresler MJ | |
| P2860 | cites work | Cell damage in the brain: a speculative synthesis | Q34253066 |
| | Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis | Q37008397 |
| | Coronary angioplasty for acute myocardial infarction | Q39488630 |
| | Thrombolytic therapy for unstable angina pectoris: rationale and results | Q39597692 |
| | Thrombolytic therapy of acute pulmonary embolism: current status and future potential | Q39597700 |
| | Investigational use of tPA in acute stroke | Q39607054 |
| | The investigational use of tPA for stroke | Q39607059 |
| | Thrombolytic therapy in the treatment of peripheral arterial occlusions | Q39607062 |
| | Acute pulmonary embolism treated with thrombolytic agents: current status of tPA and future implications for emergency medicine | Q39607069 |
| | Oxygen radicals and human disease | Q39668375 |
| | The maintenance of a sustained thrombolytic state in man. I. Induction and effects | Q40330969 |
| | Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration | Q40983602 |
| | Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis | Q41432704 |
| | A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction | Q41783750 |
| | Feasibility of pre-hospital fibrinolytic therapy in acute myocardial infarction | Q42085035 |
| | A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectoris | Q44091205 |
| | Thrombolytic therapy: Current status | Q44180381 |
| | The aggressive war on acute myocardial infarction: is the blitzkrieg strategy changing? | Q46636728 |
| | Selective Clot Lysis with Low-Dose Streptokinase | Q47886263 |
| | A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits. | Q54155648 |
| | Update from the Thrombolysis in Myocardial Infarction Trial | Q68189388 |
| | Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial | Q69367792 |
| | Acute pulmonary embolism treated with tissue plasminogen activator | Q69887713 |
| | Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism | Q69921554 |
| | Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with intravenous tissue plasminogen activator | Q70040001 |
| | Coronary revascularization after intravenous tissue plasminogen activator for unstable angina pectoris: results of a randomized, double-blind, placebo-controlled trial | Q70060447 |
| | Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group | Q70063699 |
| | Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism | Q70373273 |
| | Thrombolytic therapy in thrombosis: a National Institutes of Health consensus development conference | Q71256624 |
| | Popliteal artery thrombosis treated with streptokinase | Q76468787 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | thrombolysis | Q1931577 |
| P304 | page(s) | 1331-1338 | |
| P577 | publication date | 1989-12-01 | |
| P1433 | published in | Annals of Emergency Medicine | Q4767847 |
| P1476 | title | Future role of thrombolytic therapy in emergency medicine | |
| P478 | volume | 18 | |